UDENYCA is a pegfilgrastim biosimilar administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia. “It’s exciting to have a new ...

“Our market studies showed a significant demand for a novel on-body pegfilgrastim delivery device ... “Our state-of-the-art UDENYCA ONBODY device is unlike other approaches in that it is ...